FDA Addresses Medical Product Misinformation For The Post-COVID World

The FDA’s updated guidance on internet responses to misinformation adds considerations for a post-COVID, social media influencer world. 

• Source: Shutterstock

With every new website or app, there springs a new avenue for misinformation, and 10 years after it first addressed the topic, the US Food and Drug Administration has updated its advice for device and drug makers looking to combat it.

The 8 July guidance, Addressing Misinformation About Medical Devices and Prescription Drugs Questions and Answers Guidance for Industry, replaces...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Guidance

More from Compliance